# Effective Treatment of Hepatitis C in Substance Users

> **NCT00633243** · NA · COMPLETED · sponsor: **Yale University** · enrollment: 21 (actual)

## Conditions studied

- Hepatitis C
- Opiate Dependence

## Interventions

- **PROCEDURE:** Modified Directly Observed Therapy (mDOT)
- **PROCEDURE:** Self-Administered Therapy (SAT)

## Key facts

- **NCT ID:** NCT00633243
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2013-01-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00633243

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00633243, "Effective Treatment of Hepatitis C in Substance Users". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00633243. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*